The National Institute for Health and Care Excellence (NICE) has recommended brentuximab vedotin combined with doxorubicin, ...

A research team led by Prof. Gu Hongcang from the Hefei Institutes of Physical Science of the Chinese Academy of Sciences has ...

Cancer Center have created a tool that uses machine learning to assess a non-Hodgkin lymphoma (NHL) patient's likely response ...

Dave Coulier and his “Full House” family are celebrating the announcement that he has beaten Non-Hodgkin Lymphoma. The actor ...

Dave Coulier's cancer is in remission! A rep for the 65-year-old 'Full House' actor confirmed that he was cancer-free after a ...

More than half of patients recently diagnosed with lymphoma or myeloma had clinically significant symptoms of anxiety or ...

From today, adults with advanced Hodgkin lymphoma have access to a new treatment, after we recommended brentuximab vedotin (brand name Adcetris) in combination with other therapies for routine NHS use ...

Dave Coulier, who shared he had been diagnosed with Non-Hodgkin lymphoma last year, had some exciting news to share on Monday ...

It is estimated that about 800 people with Hodgkin lymphoma could benefit from the decision by the National Institute for Health and Care Excellence.

On Monday, Coulier's "Full House" co-star Candace Cameron Bure shared a celebratory message on Instagram regarding Coulier's ...

A new article outlines a new tool that measures blood inflammation as a marker for poor CAR T therapy outcomes.

After a five-month battle with non-Hodgkin lymphoma, the "Full House" star receives the best news of his life.